NuChem Sciences Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 83
Employees
  • Latest Deal Type
  • PE Growth
  • Financing Rounds
  • 3
  • Investments
  • 2

NuChem Sciences General Information

Description

Provider of medical contract research services intended to identify and optimize pre-clinical candidates in the area of small molecule drug discovery. The company's services specialize in the field of medicinal chemistry, drug discovery biology and can provide custom synthesis of compounds, structure-activity-relationship design, computational drug design, enabling international biotech and pharmaceuticals industries to move their project forward quickly and efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Biotechnology
Other Industries
Practice Management (Healthcare)
Discovery Tools (Healthcare)
Primary Office
  • 2350 rue Cohen
  • Suite 201
  • Saint-Laurent, Quebec H4R 2N6
  • Canada
+1 (514) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

NuChem Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NuChem Sciences‘s full profile, request access.

Request a free trial

NuChem Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of medical contract research services intended to identify and optimize pre-clinical candidates in the area of
Biotechnology
Saint-Laurent, Canada
83 As of 2021
0000
000 0000-00-00
0000000 0000 0000

000 0000

inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
00000000 0000000000 (0000000000)
Covington, KY
0000 As of 0000
000000000 -

00000000

liquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillu
0000000000000
Cuxhaven, Germany
00 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NuChem Sciences Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CTI Clinical Trial & Consulting Services Private Debt Financed Covington, KY 0000 000000000 -
0000000000 Private Equity-Backed Cuxhaven, Germany 00 000000000000
000000 000000 Corporation Montreal, Canada
You’re viewing 3 of 3 competitors. Get the full list »

NuChem Sciences Patents

NuChem Sciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2984073-A1 Inhibitors of polynucleotide repeat-associated rna foci and uses thereof Abandoned 27-Oct-2017 0000000000
AU-2014231330-A1 Small molecule modulators of pcsk9 and methods of use thereof Abandoned 15-Mar-2013 0000000000
JP-2016511274-A Pcsk9 small molecule modulator and method of use thereof Pending 15-Mar-2013 0000000000 0
EP-2961765-A1 Small molecule modulators of pcsk9 and methods of use thereof Withdrawn 15-Mar-2013 0000000000
CA-2905237-A1 Small molecule modulators of pcsk9 and methods of use thereof Abandoned 15-Mar-2013 C07K5/0827
To view NuChem Sciences’s complete patent history, request access »

NuChem Sciences Executive Team (7)

Name Title Board Seat Contact Info
Marc LeBel Co-Owner, President & Chairman
Patrick Montpetit Chief Financial Officer
Daniel Guay Ph.D Co-Owner, Chief Scientific Officer & Executive Vice President
John Mancuso Ph.D Co-Owner, Partner & Director
Marc Janes Ph.D Co-Owner & Vice President of Business Development and Innovation
You’re viewing 5 of 7 executive team members. Get the full list »

NuChem Sciences Board Members (3)

Name Representing Role Since
0000 00000 NuChem Sciences Co-Owner, President & Chairman 000 0000
You’re viewing 1 of 3 board members. Get the full list »

NuChem Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NuChem Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore NuChem Sciences‘s full profile, request access.

Request a free trial

NuChem Sciences Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 17-Aug-2021 0000000000 000.00 Drug Discovery 0000 0000
Amplia Pharmatek 31-Oct-2019 Buyout/LBO Drug Discovery 0000 0000
To view NuChem Sciences’s complete investments history, request access »

NuChem Sciences Subsidiaries (2)

Company Name Industry Location Founded
Amplia Pharmatek Drug Discovery Montreal, Canada 2009
000000000 Drug Discovery Levis, Canada 0000
To view NuChem Sciences’s complete subsidiaries history, request access »